TL;DR: A massive study of 27.8 million Medicare beneficiaries found that exposure to fine air pollution (PM2.5) increases Alzheimer’s risk by 8.5% per unit increase—and this effect operates largely through direct brain damage, not through common health conditions like stroke or depression. The conventional thinking about air pollution and dementia involves a detour through the …
TL;DR: Microplastics circulating in your blood may accelerate Alzheimer’s and Parkinson’s disease through six shared pathways—including blood-brain barrier breakdown, chronic inflammation, and oxidative stress. You probably know plastic pollution is everywhere. Less obvious: tiny plastic fragments are crossing into your brain, accumulating in brain tissue, and potentially triggering neurodegenerative disease. A new review in Molecular …
TL;DR: Aerobic exercise matches antidepressant efficacy for depression with effect size −1.60, resistance training slightly edges aerobic for anxiety, and neither requires meeting WHO guidelines—20 minutes three times weekly still produces clinical improvement. Depression responds to a treatment that’s free, legal, and accessible: exercise. But the type matters profoundly. A comprehensive meta-analysis of 26 randomized …
TL;DR: Chemists designed a new psilocin derivative with fluorine modifications that induces sub-hallucinogenic effects in mice, sidestepping the acute psychological effects of classic psychedelics while retaining therapeutic serotonin receptor activity. Psilocybin has emerged as a clinical darling—mounting evidence shows rapid relief for depression, anxiety, and cluster headaches. But there’s a catch: the intense hallucinations and …
TL;DR: TDP43, the protein that misfires in ALS and FTD, secretly controls DNA repair genes—and when it breaks, mutations pile up in neurons, potentially explaining both neurodegeneration and the cancer link in these diseases. A protein known for its role in neurodegenerative disease has a hidden job: keeping the cell’s DNA repair crew on task. …
TL;DR: A blood test measuring phosphorylated tau-217 can predict when cognitively normal people will develop Alzheimer’s symptoms with a 3.0-3.7 year margin of error, potentially transforming how researchers identify candidates for preventive clinical trials. For decades, Alzheimer’s disease remained invisible until symptoms emerged. Brain scans could show amyloid plaques and tau tangles, but only in …
TL;DR: A psychedelic drug that activates serotonin receptors dramatically amplifies slow 5-Hz brain oscillations in visual and memory regions, suggesting a mechanism for how hallucinogens distort perception by letting internal signals override external reality. Visual perception feels stable, seamless, continuous. But that stability is an illusion orchestrated by your brain. What neuroscientists have long wondered …
TL;DR: A new blood test using three misfolded plasma proteins can identify Alzheimer’s disease with 83.44% accuracy, outperforming conventional biomarkers and offering a non-invasive screening tool years before cognitive symptoms appear. The holy grail of Alzheimer’s research isn’t a cure—yet. It’s catching the disease before memory starts to fade. By the time someone notices confusion, …
TL;DR: Scientists mapped a ctenophore’s sensory integration center in stunning 3D detail, revealing 17 distinct cell types and a blueprint for how nervous systems first evolved to process multiple senses at once. The ctenophore (pronounced “tee-noh-for”), or comb jelly, is a see-through marine animal barely bigger than your pinky. It has no brain—just a simple …
TL;DR: Cocaine hijacks a transcription factor called FosB in a brain circuit connecting the hippocampus to the nucleus accumbens, suppressing neural excitability and driving compulsive drug-seeking behavior—a mechanism that could reshape addiction treatment. The brain has two competing drives during addiction: the conscious desire to quit and the limbic system’s relentless pull toward the drug. …
